CorMedix Inc

CorMedix Inc(CRMD)价格预测

$8.260

-0.040 (-0.48%)收盘时

价格预测

1-Day Price Prediction
+1.92%
1-Week Prediction
+2.46%
1-Month Prediction
2026 Prediction
2030 Prediction

在 App 中打开以解锁更长周期的预测。

Loading chart…

CRMD 相似图表分析预测

Alphio's CRMD stock price prediction model matches the current CorMedix Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.42 (+1.92%). The 1-week path is $8.46 (+2.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 CorMedix Inc 股票吗?

CorMedix Inc (CRMD) is a good buy right now due to its recent strong financial performance, including a Q2 revenue of $101.9 million, which is a significant increase from $39.7 million a year ago, and a gross margin of 75.66%. Additionally, analysts have set a price target of $14, suggesting a 59.27% upside from the current price of $8.3. The main risk is the year-to-date change of -31.74%, indicating volatility in the stock's performance.

CRMD 股价于 Monday 收于 $8.26,此前下跌 -0.48%

CorMedix Inc (CRMD) last closed at $8.26, losing -0.48%. These facts feed the 1-day and 1-week CRMD price prediction above.

分析师一致预期

CorMedix Inc(CRMD):买入 1、持有 0、卖出 0。展望:Strong Buy。

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong sellSellNeutralBuyStrong buy
Neutral
Sell
0
Buy
1

预测驱动因素

CorMedix Inc(CRMD)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 CRMD 最接近的股票,按相似度排序。

CRMD 季节性分析

Historically the probability of a positive September return for CRMD is 97.62%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始